menu search

NVAX / Novavax to Participate in Fireside Chat at the 11th Annual SVB Leerink Global Healthcare Conference

Novavax to Participate in Fireside Chat at the 11th Annual SVB Leerink Global Healthcare Conference
GAITHERSBURG, Md., Feb. 11, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that it will participate in a fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference. Read More
Posted: Feb 11 2022, 09:25
Author Name: PRNewsWire
Views: 103163

NVAX News  

Novavax could become a penny stock: beware of the Wyckoff theory

By Invezz
November 3, 2023

Novavax could become a penny stock: beware of the Wyckoff theory

Novavax (NASDAQ: NVAX) stock price has been a huge disappointment among investors in the past few months. After peaking at $332 during the Covid-19 pa more_horizontal

Novavax to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Operational Highlights on November 9, 2023

By PRNewsWire
November 2, 2023

Novavax to Host Conference Call to Discuss Third Quarter 2023 Financial Results and Operational Highlights on November 9, 2023

GAITHERSBURG, Md. , Nov. 2, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ more_horizontal

Novavax positive on updated COVID vaccine availability in US

By Reuters
October 16, 2023

Novavax positive on updated COVID vaccine availability in US

Novavax said on Monday it was "encouraged" by the broad availability of its updated COVID-19 vaccine being rolled out in the U.S., days after rival Pf more_horizontal

Is Novavax Stock a Buy Now?

By The Motley Fool
October 16, 2023

Is Novavax Stock a Buy Now?

Novavax's coronavirus vaccine is one of the few currently authorized in the U.S. However, the company's competition is fierce in a market whose size i more_horizontal

EU delays approval of Novavax's revised COVID vaccine - FT

By Reuters
October 15, 2023

EU delays approval of Novavax's revised COVID vaccine - FT

European Union (EU) regulators have delayed the decision to give approval for Novavax's variant-tailored COVID-19 vaccine, the Financial Times said on more_horizontal

Novavax (NVAX) Stock Slides Despite Vaccine Availability

By InvestorPlace
October 13, 2023

Novavax (NVAX) Stock Slides Despite Vaccine Availability

Despite seemingly good news, shares of biotechnology firm Novavax (NASDAQ: NVAX ) suffered a significant decline. Earlier Friday morning, management a more_horizontal

Novavax's updated COVID-19 vaccines available in US pharmacies

By Reuters
October 13, 2023

Novavax's updated COVID-19 vaccines available in US pharmacies

Novavax said on Friday its updated COVID-19 vaccine was available across pharmacies in the United States. more_horizontal

Novavax (NVAX) Focuses on Diversifying Vaccines Portfolio

By Zacks Investment Research
October 10, 2023

Novavax (NVAX) Focuses on Diversifying Vaccines Portfolio

Owing to the slow uptake of Novavax's (NVAX) COVID-19 vaccine, the company is trying to develop other vaccine candidates targeting different indicatio more_horizontal


Search within

Pages Search Results: